The KEGG pathway enrichment analysis showed that DNASE1L3 could not only inhibit the JAK/STAT signal pathway but could also influence the glucose metabolism of HCC cells (Fig. 5F). Here, DNASE1L3 is linked to hepatocellular carcinoma.